hrcak mascot   Srce   HID

Pregledni rad

PHARMACOECONOMICS – CHALLENGES FOR HEALTH PROFESSIONALS

PETRA TURČIĆ   ORCID icon orcid.org/0000-0002-2621-8257 ; Department of Pharmacology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia
VANESA BENKOVIĆ ; Croatian Society for Pharmacoeconomics and Health Economics, Zagreb, Croatia
OGNJEN BRBOROVIĆ ; University of Zagreb, School of Medicine, Zagreb, Croatia
ANĐA VALENT ; Polytechnic of Zagreb, Zagreb, Croatia

Puni tekst: hrvatski, pdf (129 KB) str. 117-123 preuzimanja: 1.456* citiraj
APA 6th Edition
TURČIĆ, P., BENKOVIĆ, V., BRBOROVIĆ, O. i VALENT, A. (2016). FARMAKOEKONOMIKA  IZAZOVI ZA ZDRAVSTVENE DJELATNIKE. Acta medica Croatica, 70 (2), 117-123. Preuzeto s https://hrcak.srce.hr/165170
MLA 8th Edition
TURČIĆ, PETRA, et al. "FARMAKOEKONOMIKA  IZAZOVI ZA ZDRAVSTVENE DJELATNIKE." Acta medica Croatica, vol. 70, br. 2, 2016, str. 117-123. https://hrcak.srce.hr/165170. Citirano 27.10.2021.
Chicago 17th Edition
TURČIĆ, PETRA, VANESA BENKOVIĆ, OGNJEN BRBOROVIĆ i ANĐA VALENT. "FARMAKOEKONOMIKA  IZAZOVI ZA ZDRAVSTVENE DJELATNIKE." Acta medica Croatica 70, br. 2 (2016): 117-123. https://hrcak.srce.hr/165170
Harvard
TURČIĆ, P., et al. (2016). 'FARMAKOEKONOMIKA  IZAZOVI ZA ZDRAVSTVENE DJELATNIKE', Acta medica Croatica, 70(2), str. 117-123. Preuzeto s: https://hrcak.srce.hr/165170 (Datum pristupa: 27.10.2021.)
Vancouver
TURČIĆ P, BENKOVIĆ V, BRBOROVIĆ O, VALENT A. FARMAKOEKONOMIKA  IZAZOVI ZA ZDRAVSTVENE DJELATNIKE. Acta medica Croatica [Internet]. 2016 [pristupljeno 27.10.2021.];70(2):117-123. Dostupno na: https://hrcak.srce.hr/165170
IEEE
P. TURČIĆ, V. BENKOVIĆ, O. BRBOROVIĆ i A. VALENT, "FARMAKOEKONOMIKA  IZAZOVI ZA ZDRAVSTVENE DJELATNIKE", Acta medica Croatica, vol.70, br. 2, str. 117-123, 2016. [Online]. Dostupno na: https://hrcak.srce.hr/165170. [Citirano: 27.10.2021.]

Sažetak
Over the last 30 years, medical expenditure has increased throughout the world. The main reasons estimated to lay behind it include aging, ever more chronic diseases and new emerging diseases, new drugs, expanded indications of current drugs, and development of pharmaceutical industry. A challenge for healthcare professionals is to sustain current quality of care and enable medical innovations while attempting to contain costs. The overall goal is to demonstrate the
pharmacoeconomic value, i.e. a balance of economic, humanistic and clinical outcomes.

Ključne riječi
pharmacoeconomics; analysis; outcomes; perspectives; cost

Hrčak ID: 165170

URI
https://hrcak.srce.hr/165170

[hrvatski]

Posjeta: 1.896 *